Functional imaging for radiotherapy treatment planning: current status and future directions—a review
暂无分享,去创建一个
[1] Andrea Schaefer,et al. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[2] Bernd J Pichler,et al. Principles of PET/MR Imaging , 2014, The Journal of Nuclear Medicine.
[3] Marc Kachelrieß,et al. Dual energy CT: how well can pseudo-monochromatic imaging reduce metal artifacts? , 2015, Medical physics.
[4] Hanwen Zhang,et al. A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers , 2014, The Journal of Nuclear Medicine.
[5] Eugene Wong,et al. Dynamic contrast enhanced CT aiding gross tumor volume delineation of liver tumors: an interobserver variability study. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] W van Elmpt,et al. Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] P. Lambin,et al. Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation , 2014, PloS one.
[8] M. Philippens,et al. Repeatability of diffusion‐weighted imaging in rectal cancer , 2014, Journal of magnetic resonance imaging : JMRI.
[9] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[10] H. Thoeny,et al. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers , 2013, European Radiology.
[11] G. Reischl,et al. PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen , 2009, Journal of Nuclear Medicine.
[12] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[13] David Binns,et al. The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Jan J W Lagendijk,et al. MR guidance in radiotherapy , 2014, Physics in medicine and biology.
[15] D. Knol,et al. Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma. , 2015, European journal of radiology.
[16] Michael Baumann,et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] A. Padhani,et al. Diffusion MR imaging for monitoring of treatment response. , 2011, Magnetic resonance imaging clinics of North America.
[18] B. van Calster,et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] T. Johnson,et al. Dual-energy CT: general principles. , 2012, AJR. American journal of roentgenology.
[20] Jan-Jakob Sonke,et al. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] C. Faivre-Finn,et al. Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Fréderic Duprez,et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] Paul Kinahan,et al. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. , 2006, Medical physics.
[24] Daniela Thorwarth,et al. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images , 2013, Acta oncologica.
[25] F. V. Velden,et al. Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[26] J. Dai,et al. Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. , 2014, The British journal of radiology.
[27] J. Petersen,et al. Imaging hypoxia to improve radiotherapy outcome , 2012, Nature Reviews Clinical Oncology.
[28] R. Steenbakkers,et al. PET-based analysis of tumor glucose metabolism and tumor hypoxia before and during anti-neoplastic treatment , 2015 .
[29] Marit Holden,et al. Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. , 2012, Cancer research.
[30] Wade P. Smith,et al. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] Branislav Jeremic,et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[32] Uwe Haberkorn,et al. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] A. Houweling,et al. FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting. , 2013, Radiotherapy and Oncology.
[34] Frank Verhaegen,et al. Tissue segmentation in Monte Carlo treatment planning: a simulation study using dual-energy CT images. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] Konstantin Nikolaou,et al. Metal artifact reduction by dual energy computed tomography using monoenergetic extrapolation , 2011, European Radiology.
[36] Johan Trygg,et al. ADC texture--an imaging biomarker for high-grade glioma? , 2014, Medical physics.
[37] Jan-Jakob Sonke,et al. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.
[38] Philippe Lambin,et al. Functional MRI for radiotherapy dose painting. , 2012, Magnetic resonance imaging.
[39] J. Hoogduin,et al. Diffusion weighted MRI in head-and-neck cancer: geometrical accuracy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] Ronald Boellaard,et al. Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[41] T. Mikkelsen,et al. DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma , 2012, PloS one.
[42] Christophe Deroose,et al. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer , 2010, Acta oncologica.
[43] U. A. van der Heide,et al. The use of probability maps to deal with the uncertainties in prostate cancer delineation. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[45] Jamal Zweit,et al. An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of concept. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] R. Hicks,et al. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[47] Ronald Boellaard,et al. Parametric Methods for Quantification of 18F-FAZA Kinetics in Non–Small Cell Lung Cancer Patients , 2014, The Journal of Nuclear Medicine.
[48] Rainer Raupach,et al. Frequency split metal artifact reduction (FSMAR) in computed tomography. , 2012, Medical physics.
[49] R. Modzelewski,et al. Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3′-Deoxy-3′-18F-Fluorothymidine PET Images in Lung Cancer , 2013, The Journal of Nuclear Medicine.
[50] Edward Ashton,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2012, Definitions.
[51] Vincent Gregoire,et al. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.
[52] Harald H Quick,et al. Towards integration of PET/MR hybrid imaging into radiation therapy treatment planning. , 2014, Medical physics.
[53] Isabelle Berry,et al. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study. , 2008, International journal of radiation oncology, biology, physics.
[54] Daniela Thorwarth,et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer , 2005, BMC Cancer.
[55] Daniela Thorwarth,et al. Physical radiotherapy treatment planning based on functional PET/CT data. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[56] M. Baumann,et al. Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[57] P. Lambin,et al. A Comparative Study of the Hypoxia PET Tracers ( 18 F)HX4, ( 18 F)FAZA, and ( 18 F)FMISO in a , 2015 .
[58] K. Togashi,et al. Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET. , 2014, European journal of radiology.
[59] Pierre Vera,et al. Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[60] J. Wildberger,et al. Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: experiments and a simulation model. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] Wiro J Niessen,et al. Feasibility of multimodal deformable registration for head and neck tumor treatment planning. , 2014, International journal of radiation oncology, biology, physics.
[62] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[63] G. Andreisek,et al. Metallic artefact reduction with monoenergetic dual-energy CT: systematic ex vivo evaluation of posterior spinal fusion implants from various vendors and different spine levels , 2012, European Radiology.
[64] J. Steinbach,et al. Two or four hour ( 18 F)FMISO-PET in HNSCC is the contrast best? , 2011 .
[65] B. Hoeben,et al. 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome , 2013, The Journal of Nuclear Medicine.
[66] P. Luijten,et al. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[67] Anne Bol,et al. A gradient-based method for segmenting FDG-PET images: methodology and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[68] N. Schwenzer,et al. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning , 2013, Acta oncologica.
[69] Wouter van Elmpt,et al. Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] Thomas Beyer,et al. A combined PET/CT scanner: the path to true image fusion. , 2002, The British journal of radiology.
[71] K. Murase,et al. Radiotherapy treatment planning with contrast-enhanced computed tomography: feasibility of dual-energy virtual unenhanced imaging for improved dose calculations , 2014, Radiation oncology.
[72] Heidi Lyng,et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[73] Yue Cao,et al. DCE-MRI defined subvolumes of a brain metastatic lesion by principle component analysis and fuzzy-c-means clustering for response assessment of radiation therapy. , 2013, Medical physics.
[74] W. Oyen,et al. Influence of experience and qualification on PET-based target volume delineation , 2014, Strahlentherapie und Onkologie.
[75] T. Yen,et al. Dynamic Contrast-Enhanced MR Imaging Predicts Local Control in Oropharyngeal or Hypopharyngeal Squamous Cell Carcinoma Treated with Chemoradiotherapy , 2013, PloS one.
[76] Yun-bin Chen,et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. , 2014, Magnetic resonance imaging.
[77] M Partridge,et al. Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. , 2006, The British journal of radiology.
[78] M. Reiser,et al. Material differentiation by dual energy CT: initial experience , 2007, European Radiology.
[79] John L. Humm,et al. Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer , 2010, Journal of Nuclear Medicine.
[80] Daniela Thorwarth,et al. Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps , 2011, Physics in medicine and biology.
[81] P. Castaldi,et al. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[82] Rajan Jain,et al. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications , 2013, NMR in biomedicine.
[83] Kristin D. Brockway,et al. What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. , 2012, International journal of radiation oncology, biology, physics.
[84] Søren M Bentzen,et al. Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.
[85] J. Tonn,et al. FET-PET for malignant glioma treatment planning. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[86] X Allen Li,et al. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer. , 2014, International journal of radiation oncology, biology, physics.
[87] Kari Tanderup,et al. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer , 2013, Acta oncologica.
[88] E Spezi,et al. Evaluation of advanced automatic PET segmentation methods using nonspherical thin-wall inserts. , 2014, Medical physics.
[89] Ronald Boellaard,et al. Effects of Image Characteristics on Performance of Tumor Delineation Methods: A Test–Retest Assessment , 2011, The Journal of Nuclear Medicine.
[90] Kari Tanderup,et al. Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer , 2014, Acta oncologica.
[91] P. Lambin,et al. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model. , 2015, International journal of radiation oncology, biology, physics.
[92] Peng Wang,et al. An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer. , 2012, Medical physics.
[93] P. Lambin,et al. Hypoxia imaging with [¹⁸F]HX4 PET in NSCLC patients: defining optimal imaging parameters. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[94] Daniela Thorwarth,et al. Multi-modality functional image guided dose escalation in the presence of uncertainties. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[95] Xiaodong Wu,et al. Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy. , 2012, IEEE transactions on medical imaging.
[96] Bernhard Sattler,et al. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[97] R. Fisher,et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] V. Grégoire,et al. A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[99] Sandra Nuyts,et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.
[100] M. Mix,et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[101] D. Heron,et al. Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy , 2014, Radiation Oncology.
[102] Steen Jakobsen,et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[103] Shiva K Das,et al. Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods. , 2013, Medical physics.
[104] T. Holland-Letz,et al. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[105] C. Terhaard,et al. Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. , 2014, Radiology.
[106] Thomas Filleron,et al. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme. , 2014, International journal of radiation oncology, biology, physics.
[107] Christian Roux,et al. A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET , 2009, IEEE Transactions on Medical Imaging.
[108] Andre Dekker,et al. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer , 2013, Acta oncologica.
[109] V. Grégoire,et al. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[110] David Jaffray,et al. Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers. , 2015, International journal of radiation oncology, biology, physics.
[111] Ursula Nestle,et al. Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.
[112] E. J. van der Jagt,et al. Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[113] P. Lambin,et al. In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging , 2014, Clinical Cancer Research.
[114] W. V. van Elmpt,et al. Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities. , 2014, Journal of thoracic disease.
[115] Wim J. G. Oyen,et al. Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[116] Dimitris Visvikis,et al. Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. , 2010, International journal of radiation oncology, biology, physics.
[117] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[118] Johannes A Langendijk,et al. PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III–IV Non–Small Cell Lung Cancer Patients , 2013, The Journal of Nuclear Medicine.
[119] J. Steinbach,et al. Two or four hour [18F]FMISO-PET in HNSCC , 2011, Nuklearmedizin.
[120] M. Philippens,et al. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiation , 2015, Journal of magnetic resonance imaging : JMRI.